Option Care Health, Inc. (NASDAQ:OPCH) Receives $30.83 Average Target Price from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has earned an average rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $30.83.

Several research firms recently commented on OPCH. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $38.00 to $27.00 in a research note on Monday. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $23.50 on Monday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a fifty-two week low of $22.25 and a fifty-two week high of $34.63. The stock has a market cap of $4.00 billion, a PE ratio of 19.75, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. The stock has a fifty day moving average of $30.14 and a 200-day moving average of $29.79.

Insider Buying and Selling

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of OPCH. Norden Group LLC increased its stake in shares of Option Care Health by 42.3% during the first quarter. Norden Group LLC now owns 15,138 shares of the company’s stock valued at $508,000 after purchasing an additional 4,501 shares in the last quarter. Diversify Advisory Services LLC bought a new stake in Option Care Health in the first quarter worth $307,000. FORA Capital LLC grew its stake in shares of Option Care Health by 109.7% in the first quarter. FORA Capital LLC now owns 23,011 shares of the company’s stock worth $772,000 after acquiring an additional 12,037 shares during the last quarter. GSA Capital Partners LLP bought a new position in shares of Option Care Health during the first quarter valued at $464,000. Finally, Texas Permanent School Fund Corp raised its position in shares of Option Care Health by 1.3% in the 1st quarter. Texas Permanent School Fund Corp now owns 155,023 shares of the company’s stock worth $5,199,000 after purchasing an additional 2,008 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.